30.06.2026 | GEMEINSAME PRESSEMITTEILUNG 009/2026 Globale CEOs forschender Pharma-Unternehmen reagieren auf Reformvorschlag zum GKV-Beitragssatzstabilisierungsgesetz
Publisher
Germany
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- VFA Germany
- Region
- Germany
- Scope
- Regulatory
- Published
- January 1, 1970
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on vfa.de
Leave the platform to read the original full article on the publisher site.
Source: VFA Germany
Scope: Regulatory
Related coverage
More related coverage
PRAC juni 2026: herziening afgerond van veiligheidssignaal over valproaat en verwante stoffen en aanbeveling voor gezondheidszorgbeoefenaars met nieuwe veiligheidsgegevens over chikungunya-vaccin Ixchiq
National Chlamydia Screening Programme (NCSP): incident reporting policy
Policy to report incidents during delivery of chlamydia screening to the UK Health Security Agency (...
MRSA, MSSA, Gram-negative bacteraemia and CDI: monthly data, 2025 to 2026
MRSA, MSSA, Gram-negative bacteraemia infections by organisation and location of onset, and Clostrid...
RSV vaccination: expansion of eligibility to older adults in certain clinical risk groups
Information on the expansion of the eligibility criteria of the older adults respiratory syncytial v...